| 摘要 |
ATG-1639 polypeptides and polynucleotides and methods for producing such polypep tides by recombinant techniques are disclosed. Also disclosed are methods for utilizin g ATG-1639 polypeptides and polynucleotides in the design of protocols for the treatment of heart disease, hypertension, cardiovascular diseases, kidney diseases, obesity, insulin resista nce, diabetes, CNS diseases, additions., among others, and diagnostic assays for such conditions.
|
